Piper Therapeutics

Drug discovery and development for moderating macrophages, with initial focus on immuno-oncology

Piper Therapeutics is a pre-clinical drug discovery company that develops therapies for its clients. The company develops therapies for inflammatory signaling and immune system response. Furthermore, it develops macrophages that offers services in immuno-oncology. Piper Therapeutics was founded in 2015 by Russ Wilcox and is based in Cambridge.